Qingeng Li

Title: Qingeng Li: Innovator in Pharmaceutical Chemistry

Introduction

Qingeng Li is a notable inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work primarily focuses on the development of novel compounds with therapeutic applications.

Latest Patents

One of his latest patents is for a crystalline form of ethyl (S)-3-(8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,2-a][1,4]diazepin-4-yl)propanoate hydrochloride. This invention provides a crystalline form of a benzodiazepine derivative hydrochloride, along with a method for its preparation and a pharmaceutical composition comprising the crystal form. Another significant patent is related to an etomidate derivative and its intermediates, which showcases good anesthetic activity, rapid onset, and a favorable safety profile.

Career Highlights

Qingeng Li has worked with Jiangsu Nhwaluokang Pharmaceutical Research and Development Co., Ltd., where he has contributed to various innovative projects. His expertise in pharmaceutical research has led to advancements in anesthetic compounds and their formulations.

Collaborations

Throughout his career, Qingeng Li has collaborated with notable colleagues, including Tao Wang and Lingguo Zeng. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Qingeng Li's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to impact the development of effective therapeutic agents.